Skip to main content

Beneficial ownership — 13D / 13G

85,017 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Douglas Eden HWBK Hawthorn Bancshares, Inc. 13G 9.7% 2y
BC Perception Holdings, LP CERE Cerevel Therapeutics Holdings, Inc. Common Stock 13D/A 36.4% 2y
Dapice Joshua J. CZOO Cazoo Group Ltd 13D/A 14.6% 2y
Volkswagen AG XPEV Xpeng Inc. 13G 6.1% 2y
SMC Holdings II G.P., LLC OSA ProSomnus, Inc. Common Stock 13D/A 36.6% 2y
JAT Capital Mgmt LP NXH Neighborhood Intelligence, Inc. 13G 8.3% 2y
Saba Capital Management, L.P. NQP NUVEEN PENNSYLVANIA QUALITY MUNICIPAL INCOME FUND 13D/A 11.87% 2y
TORO 18 HOLDINGS LLC UEIC Universal Electronics Inc 13D/A 11.9% 2y
Starboard Value LP GDDY GoDaddy Inc. 13D/A 6.2% 2y
Flawless Management Inc. GASS StealthGas Inc. 13D/A 28.9% 2y
STILWELL JOSEPH WHLR Wheeler Real Estate Investment Trust, Inc. 13D/A 49.99% 2y
Bluescape Energy Partners IV GP LLC FEAM 5E Advanced Materials, Inc. 13D 7.6% 2y
EW Healthcare Partners, L.P. EYPT EyePoint, Inc. 13D/A 5% 2y
Harraden Circle Investments, LLC AFJK Aimei Health Technology Co., Ltd. 13G 8.7% 2y
VANGUARD GROUP INC RVLV Revolve Group, Inc. 13G/A 10.01% 2y
Wealthspring Capital LLC USAR USA Rare Earth, Inc. 13G 12% 2y
MORGAN STANLEY FTAI FTAI Aviation Ltd. 13G/A 3.4% 2y
MORGAN STANLEY ALIM Alimera Sciences, Inc. 13G/A 1.8% 2y
BRANDES INVESTMENT PARTNERS, LP PAHC Phibro Animal Health Corp 13G 10.03% 2y
MORGAN STANLEY VERU Veru Inc. 13G/A 4.2% 2y
VANGUARD GROUP INC FHI Federated Hermes, Inc. 13G/A 10.1% 2y
VANGUARD GROUP INC DOUG Douglas Elliman Inc. 13G/A 5.1% 2y
MACKENZIE FINANCIAL CORP TIXT TELUS International (Cda) Inc. Subordinate Voting Shares 13G 8.77% 2y
MORGAN STANLEY DLY DoubleLine Yield Opportunities Fund 13G/A 4.3% 2y
Driehaus Capital Management LLC XPOF Xponential Fitness, Inc. 13G 1.78% 2y
VANGUARD GROUP INC ATRC AtriCure, Inc. 13G/A 10.01% 2y
ALLIANCEBERNSTEIN L.P. SUNL Sunlight Financial Holdings, Inc. 13G/A 5.2% 2y
MORGAN STANLEY TXG 10x Genomics, Inc. 13G/A 3.5% 2y
VANGUARD GROUP INC MURA Mural Oncology plc Ordinary Shares 13G 11.17% 2y
VANGUARD GROUP INC CRI Carters Inc 13G/A 10.04% 2y
NEUBERGER BERMAN GROUP LLC XPEL XPEL, Inc. 13G/A 0% 2y
MORGAN STANLEY GLOB Globant S.A. 13G/A 3.4% 2y
VANGUARD GROUP INC RMAX RE/MAX Holdings, Inc. 13G/A 5.48% 2y
VANGUARD GROUP INC DG Dollar General Corp 13G/A 10.03% 2y
CITY OF LONDON INVESTMENT MANAGEMENT CO LTD IIF Morgan Stanley India Investment Fund, Inc. 13G/A 10.3% 2y
MORGAN STANLEY AMRN Amarin Corp Plcuk 13G/A 1.6% 2y
VANGUARD GROUP INC QCOM Qualcomm Inc 13G/A 10.02% 2y
MORGAN STANLEY MELI Mercadolibre Inc 13G/A 3.9% 2y
GOLDMAN SACHS GROUP INC ALOR ALSP Orchid Acquisition Corporation I Class A Ordinary Share 13G/A 0% 2y
MORGAN STANLEY CHWY Chewy, Inc. 13G/A 4% 2y
VANGUARD GROUP INC KNF Knife River Corp 13G 10.76% 2y
Altai Capital Management, L.P. SKYH Sky Harbour Group Corp 13G 36.8% 2y
CITY OF LONDON INVESTMENT MANAGEMENT CO LTD ASA ASA Gold & Precious Metals Ltd 13G/A 3.1% 2y
VANGUARD GROUP INC BG Bunge Global SA 13G 11.45% 2y
VANGUARD GROUP INC DD DuPont de Nemours, Inc. 13G/A 10.46% 2y
VANGUARD GROUP INC WSR Whitestone REIT 13G/A 11.16% 2y
VANGUARD GROUP INC INCY Incyte Corp 13G/A 10.02% 2y
VANGUARD GROUP INC PDCO Patterson Companies, Inc. 13G/A 10.02% 2y
VANGUARD GROUP INC HQY Healthequity, Inc. 13G/A 10.05% 2y
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC KAI Kadant Inc 13G 11.31% 2y